WASHINGTON, July 1 (Xinhuanet) -- The US Food and Drug Administration (FDA) on Friday issued a second public health advisory on possible increased risk of suicide in adults treated with antidepressants.

    The move was in response to recent scientific reports on the subject.

    The US government health agency said it had already begun the review of available data to determine whether taking antidepressants can lead to increased risk of suicide in adults, as it is so in children.

    The FDA said the review will involve hundreds of clinical trials and may take more than a year to complete.

    In the advisory to health care providers and patients, the FDA said that adults treated with antidepressants for depression should be watched closely for condition worsening and for increased suicide thinking or behavior, particularly when they first start the medicine or change a dose.

    The recommendations are consistent with warnings already present in FDA-approved labeling for antidepressants used by adults. Enditem